We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Myriad Genetics
MYGN
$312M
| $7.94M | ﹤0.01% |
291,634
-16,689
| -5% | -$459K |
|
|
MDC
1727
DELISTED
M.D.C. Holdings, Inc.
MDC
| $7.93M | ﹤0.01% |
224,560
-58,995
| -21% | -$2.22M |
|
|
ACHN
1728
DELISTED
Achillion Pharmaceuticals
ACHN
| $7.91M | ﹤0.01% |
1,312,109
-1,840,177
| -58% | -$10.7M |
|
1729
Travere Therapeutics
TVTX
$5.78B
| $7.91M | ﹤0.01% |
556,986
-16,089
| -3% | -$206K |
|
1730
Clearway Energy Class C
CWEN
$6.7B
| $7.91M | ﹤0.01% |
396,388
+62,210
| +19% | +$1.2M |
|
|
BRKL
1731
DELISTED
Brookline Bancorp
BRKL
| $7.89M | ﹤0.01% |
479,212
+40,417
| +9% | +$637K |
|
1732
TechnipFMC
FTI
$27.3B
| $7.88M | ﹤0.01% |
494,315
-26,142
| -5% | -$405K |
|
|
NVTA
1733
DELISTED
Invitae Corporation
NVTA
| $7.86M | ﹤0.01% |
487,216
+7,177
| +1% | +$127K |
|
1734
Boot Barn
BOOT
$4.95B
| $7.83M | ﹤0.01% |
175,893
+76
| +0% | +$3K |
|
1735
Ambarella
AMBA
$3.81B
| $7.83M | ﹤0.01% |
129,252
+3,971
| +3% | +$220K |
|
1736
Anika Therapeutics
ANIK
$287M
| $7.82M | ﹤0.01% |
150,751
-60,919
| -29% | -$3.54M |
|
|
ALLK
1737
DELISTED
Allakos
ALLK
| $7.81M | ﹤0.01% |
81,861
+5,146
| +7% | +$452K |
|
1738
Huazhu Hotels Group
HTHT
$13B
| $7.78M | ﹤0.01% |
194,200
-1,700
| -0.9% | -$61.4K |
|
1739
Worthington Enterprises
WOR
$2.86B
| $7.77M | ﹤0.01% |
298,781
-640
| -0.2% | -$15.1K |
|
1740
LGI Homes
LGIH
$1.4B
| $7.76M | ﹤0.01% |
109,909
-1,566
| -1% | -$119K |
|
1741
The Greenbrier Companies
GBX
$1.46B
| $7.75M | ﹤0.01% |
238,907
+24,565
| +11% | +$735K |
|
|
GCP
1742
DELISTED
GCP Applied Technologies Inc.
GCP
| $7.72M | ﹤0.01% |
339,827
-528,067
| -61% | -$11.4M |
|
1743
InterDigital
IDCC
$8.89B
| $7.7M | ﹤0.01% |
141,367
-1,333
| -0.9% | -$73.6K |
|
|
AGR
1744
DELISTED
Avangrid, Inc.
AGR
| $7.7M | ﹤0.01% |
150,487
-13,002
| -8% | -$647K |
|
1745
MacroGenics
MGNX
$257M
| $7.69M | ﹤0.01% |
706,895
+3,007
| +0.4% | +$29.8K |
|
1746
White Mountains Insurance
WTM
$5.13B
| $7.68M | ﹤0.01% |
6,887
-11,246
| -62% | -$12.3M |
|
1747
Compañía de Minas Buenaventura
BVN
$8.67B
| $7.66M | ﹤0.01% |
506,993
+176,200
| +53% | +$2.61M |
|
1748
Hope Bancorp
HOPE
$1.79B
| $7.65M | ﹤0.01% |
515,119
-8,604
| -2% | -$125K |
|
1749
United Parks & Resorts
PRKS
$2.12B
| $7.63M | ﹤0.01% |
240,577
-25,101
| -9% | -$724K |
|
1750
Coeur Mining
CDE
$17.9B
| $7.59M | ﹤0.01% |
939,633
+76,403
| +9% | +$471K |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.